Demand for Swine Flu vaccine

Manufacturers will be stretched to meet levels of demand that will very likely reach global proportions. Glaxo Smithkline have already admitted they will need to cut some corners to satisfy demands. They will be adding chemical agents called adjuvants to their vaccines to make them stretch a bit further. Adjuvants work by stimulating the immune system enabling them to make antibodies in the presence of reduced amounts of vaccine. It is risky because adjuvants may not be enough to prevent the need for a second dose of vaccine which may be needed to provide full immunity.